3 The UK Teratology Information Service (UKTIS), which advises clinicians on medication use during pregnancy, adds that GLP-1 medication at any stage in pregnancy is not, on its own, a reason to consider ending the pregnancy or to add extra scans or tests beyond your standard antenatal care
T1 offers a promising approach for maintaining immune resilience throughout the aging process
This suggests there could be inherited traits that affect airway structure or body fat distribution
Week-by-week dosage comparison Weight loss comparison at matched timepoints *Tirzepatide 24 and 48-week figures estimated from SURMOUNT-1 trajectory data, as primary endpoint was 72 weeks
Returning it to the fridge does not reset the clock
Starting during a period of stable disease, rather than during a flare, reduces the risk of confounding symptom changes